Ina Pretzell

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

Essen University Hospital

Ina Pretzell is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in precision oncology, protein kinase inhibitors, and targeted cancer therapy.

Publications per year

2024–2025

Publications

Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)

David P. Witte, Ina Pretzell, Timm M. Reißig et al. · Journal of Cancer Research and Clinical Oncology · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +14

<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors

Helena Lanzafame, Christoph E. Heilig, Eva Wardelmann et al. · Journal of Nuclear Medicine · 2025 · 10 citations

Medicine, Nuclear Medicine, Oncology +16

1–2 of 2